Colgate-Palmolive Company (CL) Analyst Ratings & Price Targets

Colgate-Palmolive Company

CL · NYSE

Analyst Consensus

Hold

19 analysts

$88

Current

—

Low

$100

Average

—

High

Average target implies +14.22% versus the current price.

Analyst Ratings Synthesis

Consensus is Hold among 19 analysts, with a mean price target of $100. The supplied consensus provides no low or high target, so it does not establish where targets cluster or how wide the dispersion is. It also does not identify the most bullish or least bullish analyst, and the supplied evidence contains no attributable rating revisions during the week. The substantive debate visible in the research is therefore operational rather than target-specific: Colgate’s earnings and revenue beat, organic-sales growth and margin expansion support the constructive case, while the second-quarter profit decline and higher brand investment support caution. The evidence does not support a more detailed analyst-level split.

Rating Actions

No individual rating actions have been captured for CLyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Research Reports

Links to freely available third-party research. Outlook labels are our classification of each article's stance, not a rating of our own.

Covering Firms

B OF A GLBL RES

BARCLAYS CAPITA

CITIGROUP

DBS BANK

DEUTSCHE BK SEC

EDWARD JONES

EVERCORE ISI

GOLDMAN SACHS

HSBC GLOBAL RES

JEFFERIES & CO.

JP MORGAN SECUR

MORGAN STANLEY

RAYMOND JAMES

RBC CAPITAL

SANFORD BERNSTE

STIFEL NICOLAUS

UBS

WELLS FARGO SEC

ZACKS RESEARCH

Symbol: CL
Type: Stock
Sector: Consumer Discretionary
Industry: Perfumes, Cosmetics & Other Toilet Preparations
Exchange: NYSE

Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Hill's Prescription Diet, Hill's Science Diet, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom's of Maine. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water and improving children's oral health through our Colgate Bright Smiles, Bright Futures program, which has reached approximately two billion children and their families since 1991.

Key Issues

Bullish view

The second quarter showed organic-sales growth, productivity improvements and gross-margin expansion, which together offset higher advertising and brand investment. This suggests Colgate can fund demand-building spending while still improving operating performance.

Bearish view

Second-quarter profit declined despite higher sales, indicating that advertising and other pressures may be absorbing the margin benefit. Continued brand investment could limit earnings conversion even if revenue remains resilient.

Analyst Consensus

See all

Hold

19 analysts

$88

Current

—

Low

$100

Average

—

High

Average target implies +14.22% versus the current price.

Earnings History

BeatMissNo estimate

Colgate-Palmolive Company

Analyst Consensus

Analyst Ratings Synthesis

Rating Actions

Research Reports

Covering Firms

Peers